Recently Published Research & Papers

Loss-of-function and gain-of-function mutations in PPP3CA cause two distinct disorders.

​

Novel calcineurin A (PPP3CA) variant associated with epilepsy, constitutive enzyme activation and downregulation of protein expression.

De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures.

​

Early-onset infant epileptic encephalopathy associated with a de novo PPP3CA gene mutation.

​

​

PPP3CA truncating variants clustered in the regulatory domain cause early-onset refractory epilepsy.

PPP3CA Gene Mutations Cause a Severe Neurodevelopmental Disease and Seizures.

​

​